CLASS II ONGOING Drug recall · Reported 15 Jan 2025 · FDA Enforcement Report
medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL recalled
Eugia US is recalling medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, distributed nationwide in the US. The recall was initiated on 18 Dec 2024 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0185-2025
- FDA event ID
- 96018
- Recalling firm
- Eugia US, East Windsor, NJ
- Manufacturer
- Eugia US LLC
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 18 Dec 2024
- FDA classified
- 6 Jan 2025
- Reported
- 15 Jan 2025
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Manufacturing (CGMP) Deviations
- Drug class
- Injectable & IV Drugs
Timeline
| 18 Dec 2024 | Recall initiated by company | |
| 6 Jan 2025 | Classified by FDA | +19 days |
| 15 Jan 2025 | Published in enforcement report | +9 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
CGMP Deviations
Product as listed by the FDA
medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd in India for: Eugia US LLC, NJ 08520 NDC 55150-329-01 Shipper label: medroxyPROGESTERone Acetate Injectable Suspension, USP, 150 mg per mL, Distributed by: Eugia US LLC, NJ, Manufactured by: Eugia Pharma Specialties Limited, India
Where it was distributed
Nationwide in the US
Questions about this recall
Why was it recalled?
CGMP Deviations
Which lots are affected?
Lot No.: 1MP24069, Exp.: 08/2026
Where was it sold?
Nationwide in the US
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Eugia US
All 17| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Lidocaine HCl Injection, USP 2%, 40 mg recalled by Eugia USLidolog Kit | Eugia US | Other | Nationwide |
| Drug | CLASS II | Gentamicin Injection, USP, (Pediatric), 20 mg recalled by Eugia USGentamicin | Eugia US | Potency & Assay | Nationwide |
| Drug | CLASS II | Tirofiban Hydrochloride Injection 5 mg recalled by Eugia USTirofiban | Eugia US | Potency & Assay | Nationwide |
| Drug | CLASS II | Tirofiban Hydrochloride Injection 12.5 mg recalled by Eugia USTirofiban | Eugia US | Potency & Assay | Nationwide |
| Drug | CLASS II | Testosterone Cypionate Injection, USP, CIII, 200mg per mL recalledTestosterone Cypionate | Eugia US | Manufacturing (CGMP) Deviations | Nationwide |
Other Medroxyprogesterone recalls
All 24| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Medroxyprogesterone Acetate Injectable Suspension recalled | Mckesson Medical-Surgical Inc. Corporate Office | Potency & Assay | FL, MS |
| Drug | CLASS II | Medroxyprogesterone Acetate 300 MG/ML Suspension vial recalled | Pharmacy Plus | Sterility | 4 states |
| Drug | CLASS II | medroxyPROGESTERone Acetate Injectable Suspension recalled | SUN Pharmaceutical Industries | Sterility | Nationwide |
| Drug | CLASS II | medroxyPROGESTERone Acetate Injectable Suspension recalled | SUN Pharmaceutical Industries | Sterility | Nationwide |
| Drug | CLASS II | medroxyPROGESTERone Acetate Injectable Suspension recalledMedroxyprogesterone Acetate | SUN Pharmaceutical Industries | Sterility | Nationwide |